Royalty Pharma announced the appointment of Eric Schneider as Senior Vice President, Chief Technology Officer. Eric will also join Royalty Pharma’s Senior Leadership Committee. Eric joins Royalty Pharma from Verisk, a global leader in data-driven analytic insights and solutions, where he was a Senior Vice President, Chief Data Officer and Chief Technology Officer, and a member of the Executive Leadership Team.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RPRX:
- Royalty Pharma Appoints Eric Schneider as Chief Technology Officer
- Ascendis Pharma price target raised to $113 from $107 at BofA
- Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
- Ascendis Pharma and Royalty Pharma enter into $150M royalty funding pact
- Royalty Pharma to Present at Upcoming Investor Conferences